| ACIP |
Advisory Committee on Immunization Practices
|
IIS |
Immunization Information Systems |
| Anti-FHA |
Antibody directed against filamentous hemagglutinin
|
IPV |
Inactivated poliovirus vaccine |
| Anti-FIM |
Antibody directed against fimbrial proteins |
IM |
intramuscularly |
| Anti-PRN |
Antibody directed against pertactin |
IOM |
Institute of Medicine |
| Anti-PT |
Antibody directed against pertussis toxin |
IU |
international units |
| CI |
confidence interval |
Lf |
limit of flocculation unit |
| CSTE |
Council of State and Territorial Epidemiologists
|
MCV4 |
Quadrivalent meningococcal conjugate vaccine |
| DFA |
direct fluorescent antibody |
mL |
Milliliter |
| DT |
pediatric diphtheria and tetanus toxoids vaccine
|
NNDSS |
National Notifiable Disease surveillance System |
| DTaP |
pediatric diphtheria and tetanus toxoids
and acellular pertussis vaccine |
PCR |
polymerase chain reaction |
| DTP |
pediatric diphtheria and tetanus toxoids
and whole-cell pertussis vaccine |
PRN |
pertactin, 69kDa protein |
| ELISA |
Enzyme-linked immunoabsorbant assay |
PPD |
tuberculin purified protein derivative |
| FDA |
Food and Drug Administration |
PT |
pertussis toxin, lymphocytosis promoting factor |
| FHA |
filamentous hemagglutinin |
Tdap |
adult tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine |
| FIM |
Fimbriae |
Td |
adult tetanus and reduced diphtheria toxoids vaccine |
| GMC |
geometric mean antibody concentration |
TIG |
tetanus immune globulin |
| Hep |
B Hepatitis B vaccine |
TIV |
trivalent inactivated influenza vaccine |
| Hib |
Haemophilus influenzae type b |
TT |
tetanus toxoid vaccine |
| |
|
VAERS |
Vaccine Adverse Event Reporting System |
| |
|
VICP |
Vaccine Injury Compensation Program |
| |
|
WHO |
World Health Organization |